Status:
COMPLETED
A Cluster Randomized Trial to Assess the Impact of Opinion Leader Endorsed Evidence Summaries on Improving Quality of Prescribing for Patients With Chronic Cardiovascular Disease
Lead Sponsor:
University of Alberta
Collaborating Sponsors:
Alberta Heritage Foundation for Medical Research
Institute of Health Economics, Canada
Conditions:
Coronary Disease
Ischemic Heart Disease
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
BACKGROUND: Although much has been written about the influence of local opinion leaders on clinical practice, there have been few controlled studies of their effect, and almost none have attempted to ...
Detailed Description
BACKGROUND: Although much has been written about the influence of local opinion leaders on clinical practice, there have been few controlled studies of their effect, and almost none have attempted to ...
Eligibility Criteria
Inclusion
- Patients with HF or IHD who are not currently taking the study medications of interest (ACE inhibitors/angiotensin receptor blockers for HF or statins for IHD) and whose primary care physicians are part of the study population
Exclusion
- Patients who are unable or unwilling to give informed consent,
- previously taken the study medications according to dispensing records
- allergy or intolerance to study medications
- residents of long-term care facilities
- unable to confirm a diagnosis of either HF or IHD
- primary care physician has already contributed 5 patients to the study
Key Trial Info
Start Date :
January 1 2002
Trial Type :
INTERVENTIONAL
End Date :
April 1 2005
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00175279
Start Date
January 1 2002
End Date
April 1 2005
Last Update
May 10 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta
Edmonton, Alberta, Canada, T6G 2B7